跳至主要内容
临床试验/NCT05295511
NCT05295511已完成不适用

Dose-response Effects of a Recreational Team Handball-based Exercise Programme on Cardiovascular, Metabolic, Musculoskeletal and Physical Fitness Markers in Inactive Middle-aged and Older Male

University Institute of Maia1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2017年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
68
试验地点
1
主要终点
Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake

研究概览

简要总结

The present study aims at analyzing the dose-response effects of a recreational team handball-based exercise programme on cardiovascular, metabolic, musculoskeletal and physical fitness markers of inactive middle-aged and older men, without previous experience with the sport. The researchers hypothesized a positive weekly training frequency effect on health and physical fitness outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Male participants; inactive with 50 or more years of age (i.e., not complying with the physical activity guidelines for the last 6 months).

排除标准

  • •Any medical contraindication to perform moderate-to-vigorous physical activity; incapacity to run or grip a ball.

研究组 & 干预措施

Team Handball 1

Experimental

Team handball group participants were instructed to perform one weekly 60-min recreational team handball training sessions for 16 weeks.

干预措施: Recreational Team Handball programme (Other)

Team Handball 2

Experimental

Team handball group participants were instructed to perform two weekly 60-min recreational team handball training sessions for 16 weeks.

干预措施: Recreational Team Handball programme (Other)

Team Handball 3

Experimental

Team handball group participants were instructed to perform three weekly 60-min recreational team handball training sessions for 16 weeks.

干预措施: Recreational Team Handball programme (Other)

Control Group

No Intervention

The control group participants were instructed to keep their regular daily physical activity for 16 weeks.

结局指标

主要结局

Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in maximal oxygen uptake

时间窗: Baseline and week 16

Maximal oxygen uptake (mL/min/kg) was measured by pulmonary gas exchange measurements. The participants performed an incremental treadmill test until voluntary exhaustion in a laboratory, according to a standardized incremental protocol.

次要结局

  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in systolic blood pressure(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in lumbar spine bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in femur bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in diastolic blood pressure(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral density(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body bone mineral content(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in resting heart rate(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in gynoid total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right leg lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in carboxy-terminal type-1 collagen crosslinks(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in sclerostin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total antioxidant status(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in whole-body mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left leg total mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in android fat mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in left arm lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in right arm lean mass(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in total cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in low-density lipoprotein cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione peroxidase(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in procollagen type-1 amino-terminal propeptide(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in isometric upper body strength(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in triglycerides(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glutathione reductase(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in postural balance(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in aerobic performance(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in high-density lipoprotein cholesterol(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glycosylated haemoglobin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in osteocalcin(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in upper and lower body strength, and coordination(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in glucose(Baseline and week 16)
  • Within-group changes from baseline to 16 weeks, and between-group changes in week 16, in insulin(Baseline and week 16)

研究者

发起方
University Institute of Maia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Susana Cristina Araújo Póvoas

Associate Professor

University Institute of Maia

研究点 (1)

Loading locations...

相似试验